Recent articles

It was 2015—five years ago—that three organizations (BreakthroughT1D, the Endocrine Society and the American Diabetes Association) published a statement urging the adoption of a staging system of type 1 diabetes (T1D) that uses islet autoantibodies as biomarkers. (Biomarkers, in this sense, are indicators that a person is developing T1D but is still without symptoms.) It […]

We continue sharing expert responses to your top incoming questions. Note these responses are not intended to be medical advice, for that—as always—you must consult your own personal physician.

Sarah here, back again this week to share what I’ve been thinking about in the times of coronavirus as a young adult with type 1 diabetes (T1D)! As a reminder, I’m not a healthcare professional – I’m just a person with T1D who’s trying to get through this quarantine the best I can. If you […]

Three organizations—an academic institution, a non-profit and a company—are working to understand the prevalence, outcomes and risk factors for contracting COVID-19. By collecting real world data, this will inform doctors and researchers to understand the additional risks and possible treatments for people with type 1 diabetes (T1D) with the coronavirus pandemic. Two of them are specifically […]

TrialNet—an international Breakthrough T1D-supported network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams dedicated to finding cures for type 1 diabetes (T1D)—has a new in-home test kit that makes screening far more easy and convenient. And FedEx will come pick it up, at no cost to you! If you have a relative with […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.